When I started my rebalancing of my Volatility Portfolio on February 20, I thought I would add the slightly in the money Nektar Therapeutics (NKTR) calls at $80 with an expiration of August 17, 2018 at a closing price of $18.50. But the underlying stock has moved up so strongly since then that those calls […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
